Pulse Biosciences is the inventor and sole proprietor of Nanosecond Pulsed Field Ablation™ (nsPFA™) technology, dedicated to health innovation aimed at improving patient lives. This proprietary technology delivers nanosecond pulses of electrical energy to precisely target and clear cells without harming surrounding tissue. The team at Pulse Biosciences comprises experts in pulsed electric field technologies, leveraging their engineering expertise to explore various medical applications. With over 130 issued patents globally, Pulse Biosciences aims to expand its innovative technology and develop a pipeline of transformative commercial applications.